Comment on "Predictors of short-term outcomes related to central subfield foveal thickness after intravitreal bevacizumab for macular edema due to central retinal vein occlusion".

Autor: Călugăru D; Department of Ophthalmology, University of Medicine, Cluj-Napoca 400012, Romania., Călugăru M; Department of Ophthalmology, University of Medicine, Cluj-Napoca 400012, Romania.
Jazyk: angličtina
Zdroj: International journal of ophthalmology [Int J Ophthalmol] 2017 Sep 18; Vol. 10 (9), pp. 1481-1482. Date of Electronic Publication: 2017 Sep 18 (Print Publication: 2017).
DOI: 10.18240/ijo.2017.09.25
Databáze: MEDLINE